You will hear about an R&D 100 award winning technology that enables biosecurity instrumentation testing and airborne contaminants tracking. The technology is inherently safe and provides flexibility in aerosol testing.
Analysis of Waste Water Treatment in Kaduna Refining and Petrochemicals Corpo...IJERA Editor
Scientific data and results have to be accurate, precise and reliable and are subject to ever increasing scrutiny by
regulators in industry, the environment and medicine, in validation and also in research and development. Given
our numerous environmental problems, the need for accurate, precise and reliable results cannot be
overemphasized in environmental pollution control. This research was undertaken by visiting the analytical
laboratory involved in environmental pollution control in Nigerian National Petroleum Corporation (NNPC)
Kaduna which is known as Kaduna Refining and Petrochemicals (KRPC). Results were taken within a span of
three years at different times of the year. End of month results were also taken for the two receiving rivers
(River Kaduna & Romi River) and effluent from the refinery. The waste water was analyzed using available
instruments in the Refinery such as PH meter, Dissolved Oxygen (DO) Meter, Conductivity Meter, Gas
chromatography, burette, pipette, Double beam Spectrometer, and Thermometer. The results showed that many
parameters meet the standard of limit set by the Nigerian Standard Organization but there are many vital
parameters whose limits are very low but not measured for lack of instruments. The point of concern here
becomes the availability of suitable analytical instruments for quality control in the waste water treatment.
Analysis of Waste Water Treatment in Kaduna Refining and Petrochemicals Corpo...IJERA Editor
Scientific data and results have to be accurate, precise and reliable and are subject to ever increasing scrutiny by
regulators in industry, the environment and medicine, in validation and also in research and development. Given
our numerous environmental problems, the need for accurate, precise and reliable results cannot be
overemphasized in environmental pollution control. This research was undertaken by visiting the analytical
laboratory involved in environmental pollution control in Nigerian National Petroleum Corporation (NNPC)
Kaduna which is known as Kaduna Refining and Petrochemicals (KRPC). Results were taken within a span of
three years at different times of the year. End of month results were also taken for the two receiving rivers
(River Kaduna & Romi River) and effluent from the refinery. The waste water was analyzed using available
instruments in the Refinery such as PH meter, Dissolved Oxygen (DO) Meter, Conductivity Meter, Gas
chromatography, burette, pipette, Double beam Spectrometer, and Thermometer. The results showed that many
parameters meet the standard of limit set by the Nigerian Standard Organization but there are many vital
parameters whose limits are very low but not measured for lack of instruments. The point of concern here
becomes the availability of suitable analytical instruments for quality control in the waste water treatment.
Six startups born out of Lawrence Livermore National Laboratory technologies made presentations at a recent entrepreneurial event to attract investors.
The companies -- which have licensed technologies in biotech, renewable energy, sensors, infrared imaging and health care -- showcased their capabilities at the Entrepreneurs-in-Readiness (EIR) event at the Livermore Valley Open Campus' High Performance Computing Innovation Center.
The event was part of an EIR program developed by the Lab's Industrial Partnerships Office (IPO) to connect nascent companies with entrepreneurs and investors. The idea is to engage a diverse group of entrepreneurs and industry experts from Silicon Valley to help nurture promising new early stage Lab technology companies toward commercialization.
ipo.llnl.gov
You will hear about an exciting new micromirror array designed and being prototyped at LLNL. It promises faster, more accurate motion and larger range than what is currently on the market. The new design will enable advanced applications in areas such as 3D image projection and high-speed focusable LIDAR, among others.
You will hear about an LLNL developed high-efficiency filter made from ceramic materials in a metal housing. The filters are scalable and can be engineered for myriad commercial applications.
March 2013
In March we featured a technology from a fellow national laboratory. You will hear about a new portable point of care diagnostics platform to run multiple assays in minutes from a single drop of blood or other bodily fluids.
September 2012
You will hear about a prototype desalination technique that betters conventional capacitive deionization methods as well as reverse osmosis.
Six startups born out of Lawrence Livermore National Laboratory technologies made presentations at a recent entrepreneurial event to attract investors.
The companies -- which have licensed technologies in biotech, renewable energy, sensors, infrared imaging and health care -- showcased their capabilities at the Entrepreneurs-in-Readiness (EIR) event at the Livermore Valley Open Campus' High Performance Computing Innovation Center.
The event was part of an EIR program developed by the Lab's Industrial Partnerships Office (IPO) to connect nascent companies with entrepreneurs and investors. The idea is to engage a diverse group of entrepreneurs and industry experts from Silicon Valley to help nurture promising new early stage Lab technology companies toward commercialization.
ipo.llnl.gov
Six startups born out of Lawrence Livermore National Laboratory technologies made presentations at a recent entrepreneurial event to attract investors.
The companies -- which have licensed technologies in biotech, renewable energy, sensors, infrared imaging and health care -- showcased their capabilities at the Entrepreneurs-in-Readiness (EIR) event at the Livermore Valley Open Campus' High Performance Computing Innovation Center.
The event was part of an EIR program developed by the Lab's Industrial Partnerships Office (IPO) to connect nascent companies with entrepreneurs and investors. The idea is to engage a diverse group of entrepreneurs and industry experts from Silicon Valley to help nurture promising new early stage Lab technology companies toward commercialization.
ipo.llnl.gov
You will hear about an optical fiber draw tower in operation at LLNL that is researching new designs and applications for optical fibers. Optical fibers were originally developed for the telecom industry but new designs and fabrication techniques that can be researched using the LLNL draw tower are enabling uses in areas such as surgery, industrial machining, high power lasers and optical sensors
Protecting our nation's ports from terrorist attacks consumes significant resources. To help address this problem, researchers at the Lawrence Livermore National Laboratory have been developing technologies to make offshore inspection of seaborn trade using floating ports a realistic option. The March 25 webinar will take a look how container commerce can be reinvented through public/private partnerships around Lawrence Livermore technologies and capabilities.
LEARN MORE
Technology Transfer at LLNL: http://1.usa.gov/1fdJd0p
Commerce security from offshore port design: http://bit.ly/1dzwYiv
Plan floated to ship cargo inspection offshore: http://1.usa.gov/1f7flHI
"Amoeba Cysts as Natural Containers for the Transport and Storage of Pathogens" by Sahar El-Etr, LLNL Biomedical Scientist
You will hear about a unique method for transporting clinical samples from the field to a laboratory. The use of amoeba as “natural” containers for pathogens was utilized to develop the first living system for the transport and storage of pathogens. The amoeba system works at ambient temperature for extended periods of time—capabilities currently not available for biological sample transport.
ipo.llnl.gov
May 2012
You will hear about a research program in persistent surveillance. To identify terrorist activity and behavior, Livermore researchers have developed a data-processing pipeline that combines graphics-based computer hardware and clever software to extract meaning from wide-area overhead surveillance video.
October 2011
You will hear about LLNL's work in building medical sensing capabilities to enable better trauma and critical care in austere environments.
August 2012
You will hear about a patented LLNL optical diagnostic microscope design that can provide real-time imaging for tissue pathology and many other market applications.
You will hear about LLNL's computational capabilities and disruptive science available to industry through the Lab's High Performance Computing Innovation Center. Offering industrial clients and partners access to decades worth of experience and expertise, the HPCIC provides true innovation in an accessible, collaboration-friendly environment. The result is transformational solutions unachievable elsewhere.
Six startups born out of Lawrence Livermore National Laboratory technologies made presentations at a recent entrepreneurial event to attract investors.
The companies -- which have licensed technologies in biotech, renewable energy, sensors, infrared imaging and health care -- showcased their capabilities at the Entrepreneurs-in-Readiness (EIR) event at the Livermore Valley Open Campus' High Performance Computing Innovation Center.
The event was part of an EIR program developed by the Lab's Industrial Partnerships Office (IPO) to connect nascent companies with entrepreneurs and investors. The idea is to engage a diverse group of entrepreneurs and industry experts from Silicon Valley to help nurture promising new early stage Lab technology companies toward commercialization.
ipo.llnl.gov
You will hear about an exciting new micromirror array designed and being prototyped at LLNL. It promises faster, more accurate motion and larger range than what is currently on the market. The new design will enable advanced applications in areas such as 3D image projection and high-speed focusable LIDAR, among others.
You will hear about an LLNL developed high-efficiency filter made from ceramic materials in a metal housing. The filters are scalable and can be engineered for myriad commercial applications.
March 2013
In March we featured a technology from a fellow national laboratory. You will hear about a new portable point of care diagnostics platform to run multiple assays in minutes from a single drop of blood or other bodily fluids.
September 2012
You will hear about a prototype desalination technique that betters conventional capacitive deionization methods as well as reverse osmosis.
Six startups born out of Lawrence Livermore National Laboratory technologies made presentations at a recent entrepreneurial event to attract investors.
The companies -- which have licensed technologies in biotech, renewable energy, sensors, infrared imaging and health care -- showcased their capabilities at the Entrepreneurs-in-Readiness (EIR) event at the Livermore Valley Open Campus' High Performance Computing Innovation Center.
The event was part of an EIR program developed by the Lab's Industrial Partnerships Office (IPO) to connect nascent companies with entrepreneurs and investors. The idea is to engage a diverse group of entrepreneurs and industry experts from Silicon Valley to help nurture promising new early stage Lab technology companies toward commercialization.
ipo.llnl.gov
Six startups born out of Lawrence Livermore National Laboratory technologies made presentations at a recent entrepreneurial event to attract investors.
The companies -- which have licensed technologies in biotech, renewable energy, sensors, infrared imaging and health care -- showcased their capabilities at the Entrepreneurs-in-Readiness (EIR) event at the Livermore Valley Open Campus' High Performance Computing Innovation Center.
The event was part of an EIR program developed by the Lab's Industrial Partnerships Office (IPO) to connect nascent companies with entrepreneurs and investors. The idea is to engage a diverse group of entrepreneurs and industry experts from Silicon Valley to help nurture promising new early stage Lab technology companies toward commercialization.
ipo.llnl.gov
You will hear about an optical fiber draw tower in operation at LLNL that is researching new designs and applications for optical fibers. Optical fibers were originally developed for the telecom industry but new designs and fabrication techniques that can be researched using the LLNL draw tower are enabling uses in areas such as surgery, industrial machining, high power lasers and optical sensors
Protecting our nation's ports from terrorist attacks consumes significant resources. To help address this problem, researchers at the Lawrence Livermore National Laboratory have been developing technologies to make offshore inspection of seaborn trade using floating ports a realistic option. The March 25 webinar will take a look how container commerce can be reinvented through public/private partnerships around Lawrence Livermore technologies and capabilities.
LEARN MORE
Technology Transfer at LLNL: http://1.usa.gov/1fdJd0p
Commerce security from offshore port design: http://bit.ly/1dzwYiv
Plan floated to ship cargo inspection offshore: http://1.usa.gov/1f7flHI
"Amoeba Cysts as Natural Containers for the Transport and Storage of Pathogens" by Sahar El-Etr, LLNL Biomedical Scientist
You will hear about a unique method for transporting clinical samples from the field to a laboratory. The use of amoeba as “natural” containers for pathogens was utilized to develop the first living system for the transport and storage of pathogens. The amoeba system works at ambient temperature for extended periods of time—capabilities currently not available for biological sample transport.
ipo.llnl.gov
May 2012
You will hear about a research program in persistent surveillance. To identify terrorist activity and behavior, Livermore researchers have developed a data-processing pipeline that combines graphics-based computer hardware and clever software to extract meaning from wide-area overhead surveillance video.
October 2011
You will hear about LLNL's work in building medical sensing capabilities to enable better trauma and critical care in austere environments.
August 2012
You will hear about a patented LLNL optical diagnostic microscope design that can provide real-time imaging for tissue pathology and many other market applications.
You will hear about LLNL's computational capabilities and disruptive science available to industry through the Lab's High Performance Computing Innovation Center. Offering industrial clients and partners access to decades worth of experience and expertise, the HPCIC provides true innovation in an accessible, collaboration-friendly environment. The result is transformational solutions unachievable elsewhere.
Points to Consider for Molecular Detection for Respiratory VirusesIan M. Mackay, Ph.D
Lecture given by me as a WHO-EMRO Temporary Advisor, to the First WHO-EMRO Training Workshop on MERS-CoV Laboratory Diagnostics, 14th-16th December 2015, Dubai, UAE.
Humans are potentially exposed to tens of thousands of man-made chemicals in the environment. It is well known that some environmental chemicals mimic natural hormones and thus have the potential to be endocrine disruptors. Most of these environmental chemicals have never been tested for their ability to disrupt the endocrine system, in particular, their ability to interact with the estrogen receptor. EPA needs tools to prioritize thousands of chemicals, for instance in the Endocrine Disruptor Screening Program (EDSP). This project was intended to be a demonstration of the use of predictive computational models on HTS data including ToxCast and Tox21 assays to prioritize a large chemical universe of 32464 unique structures for one specific molecular target – the estrogen receptor. CERAPP combined multiple computational models for prediction of estrogen receptor activity, and used the predicted results to build a unique consensus model. Models were developed in collaboration between 17 groups in the U.S. and Europe and applied to predict the common set of chemicals. Structure-based techniques such as docking and several QSAR modeling approaches were employed, mostly using a common training set of 1677 compounds provided by U.S. EPA, to build a total of 42 classification models and 8 regression models for binding, agonist and antagonist activity. All predictions were evaluated on ToxCast data and on an external validation set collected from the literature. In order to overcome the limitations of single models, a consensus was built weighting models based on their prediction accuracy scores (including sensitivity and specificity against training and external sets). Individual model scores ranged from 0.69 to 0.85, showing high prediction reliabilities. The final consensus predicted 4001 chemicals as actives to be considered as high priority for further testing and 6742 as suspicious chemicals. This abstract does not necessarily reflect U.S. EPA policy
Anne Krug’s project measures human neurons, which are treated with different kinds of substances, to assess whether these have a negative impact on neurite growth.
FDA Feedback Regarding Chemistry for Toxicological Risk Assessment – How to M...Greenlight Guru
One of the newest biocompatibility evaluation tools is extractable and leachable (E&L) testing. A correctly run E&L study, with an accompanying toxicological evaluation, can be used to replace traditional tests like systemic toxicity, genotoxicity, reproductive toxicity, and carcinogenicity. The data gained from these studies can help understand the total risk of your device to an intended population of users; but unlike the traditional animal tests, it comes with separate risks. These tests are not your typical “stamped” tests, where every lab gives a similar quality of results. Because of this, FDA has refined a strict, detailed, list of parameters that should be included in every test. This list is very dynamic and is changing rapidly; the best way to make sure you are performing the correct version of the test is to learn from the most recent FDA feedback on studies.
TAKEAWAY ITEMS:
• Understand recent FDA feedback and dissect what FDA is asking/looking for
• Learn how to address these concerns and develop a protocol to make sure you don’t receive similar questions
• Recognize how FDA is using the new ISO 10993-18 and where they deviate from that standard
This session took place live at the Greenlight Guru True Quality Virtual Summit, a three-day event for medical device professionals to learn to get their devices to market faster, stay ahead of regulatory changes, and use quality as their multiplier to grow their device business.
Assessing the Impact of Single-Use Systems on Patient Safety: A perspective ...MilliporeSigma
Presented at INTERPHEX on March 21-23, 2017.
Single use process technology is routinely used in the manufacture of pharmaceuticals and biopharmaceuticals. The potential for extractables and leachables from single use systems and their impact on patient safety are an important focus of drug manufacturers and regulators. While current regulatory guidelines and industry standards provide general direction on compound-specific safety assessments, they do not offer a comprehensive approach to safety evaluations of extractables and leachables. Smaller, emerging companies might not even be aware of the extent of the extractables and leachables data expected by regulatory authorities and that the FDA has issued warning letters in cases where the appropriate extractables and leachables studies were missing for a drug product. The author will describe a comprehensive approach to determine the impact single use process technology has on patient safety.
•U.S. Congress mandated that the EPA screen chemicals for their potential to be endocrine disruptors
•Led to development of the Endocrine Disruptor Screening Program (EDSP)
•Initial focus was on environmental estrogens, but program expanded to include androgens and thyroid pathway disruptors
Plenary talk at ISPAC conference on the use of polycyclic aromatic hydrocarbons (PAHs) in environmental forensics. Covers basics of what enviromental forensics investigations (EFIs) are and how PAHs can be used to help determine sources of releases (creosote, railway ties), oil sands development and oil spill releases (Macondo oil spill, gulf oil spill).
Consensus Models to Predict Endocrine Disruption for All Human-Exposure Chemi...Kamel Mansouri
AAAS annual meeting (Boston, Feb 2017)
Humans are potentially exposed to tens of thousands of man-made chemicals in the environment. It is well known that some environmental chemicals mimic natural hormones and thus have the potential to be endocrine disruptors. Most of these environmental chemicals have never been tested for their ability to disrupt the endocrine system, in particular, their ability to interact with the estrogen receptor. EPA needs tools to prioritize thousands of chemicals, for instance in the Endocrine Disruptor Screening Program (EDSP). Collaborative Estrogen Receptor Activity Prediction Project (CERAPP) was intended to be a demonstration of the use of predictive computational models on HTS data including ToxCast and Tox21 assays to prioritize a large chemical universe of 32464 unique structures for one specific molecular target – the estrogen receptor. CERAPP combined multiple computational models for prediction of estrogen receptor activity, and used the predicted results to build a unique consensus model. Models were developed in collaboration between 17 groups in the U.S. and Europe and applied to predict the common set of chemicals. Structure-based techniques such as docking and several QSAR modeling approaches were employed, mostly using a common training set of 1677 compounds provided by U.S. EPA, to build a total of 42 classification models and 8 regression models for binding, agonist and antagonist activity. All predictions were evaluated on ToxCast data and on an external validation set collected from the literature. In order to overcome the limitations of single models, a consensus was built weighting models based on their prediction accuracy scores (including sensitivity and specificity against training and external sets). Individual model scores ranged from 0.69 to 0.85, showing high prediction reliabilities. The final consensus predicted 4001 chemicals as actives to be considered as high priority for further testing and 6742 as suspicious chemicals. The same approach is now being applied on a larger scale project to predict the potential androgen receptor (AR) activity of chemicals. This project called CoMPARA (Collaborative Modeling Project for Androgen Receptor Activity) is a collaboration between 35 international groups working on a common set of ~55k chemicals.
This abstract does not necessarily reflect U.S. EPA policy
10-12 April 2019: The OECD Conference on RNAi based pesticides provided an overview on the current status and future possibilities for the regulation of externally applied dsRNA-based products that are proposed for use as pesticides. The event facilitated exchanges between policy makers, academia, industry on their implications in health, environment, and regulation.
Presentation for Texas A&M Superfund Research Center virtual learning series, Big Data in Environmental Science and Toxicology. More details at https://superfund.tamu.edu/big-data-session-2-aug-18-2021/
Similar to DNATrax (DNA Tagged Reagents for Aerosol eXperiments) by George Farquar, LLNL scientist (20)
Six startups born out of Lawrence Livermore National Laboratory technologies made presentations at a recent entrepreneurial event to attract investors.
The companies -- which have licensed technologies in biotech, renewable energy, sensors, infrared imaging and health care -- showcased their capabilities at the Entrepreneurs-in-Readiness (EIR) event at the Livermore Valley Open Campus' High Performance Computing Innovation Center.
The event was part of an EIR program developed by the Lab's Industrial Partnerships Office (IPO) to connect nascent companies with entrepreneurs and investors. The idea is to engage a diverse group of entrepreneurs and industry experts from Silicon Valley to help nurture promising new early stage Lab technology companies toward commercialization.
ipo.llnl.gov
You will hear about an advancement for imaging during endoscopic surgery. The endoscopic system design and image acquisition method could provide low-cost and real-time surgical navigation capability with optimized sensitivity and functionality.
December 2012
You will hear about LLNL's capability developed around adaptive optics technology. Specifically, a retinal imaging application will be highlighted and you will be introduced to its ability to be used in a number of market applications.
Richard's entangled aventures in wonderlandRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Sérgio Sacani
Since volcanic activity was first discovered on Io from Voyager images in 1979, changes
on Io’s surface have been monitored from both spacecraft and ground-based telescopes.
Here, we present the highest spatial resolution images of Io ever obtained from a groundbased telescope. These images, acquired by the SHARK-VIS instrument on the Large
Binocular Telescope, show evidence of a major resurfacing event on Io’s trailing hemisphere. When compared to the most recent spacecraft images, the SHARK-VIS images
show that a plume deposit from a powerful eruption at Pillan Patera has covered part
of the long-lived Pele plume deposit. Although this type of resurfacing event may be common on Io, few have been detected due to the rarity of spacecraft visits and the previously low spatial resolution available from Earth-based telescopes. The SHARK-VIS instrument ushers in a new era of high resolution imaging of Io’s surface using adaptive
optics at visible wavelengths.
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
Normal Cell Metabolism:
Cellular respiration describes the series of steps that cells use to break down sugar and other chemicals to get the energy we need to function.
Energy is stored in the bonds of glucose and when glucose is broken down, much of that energy is released.
Cell utilize energy in the form of ATP.
The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is formed during this process.
Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.
The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos).
It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP. Importantly, cells need oxygen to complete oxidative phosphorylation.
If a cell completes only glycolysis, only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use.
IN CANCER CELL:
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
introduction to WARBERG PHENOMENA:
WARBURG EFFECT Usually, cancer cells are highly glycolytic (glucose addiction) and take up more glucose than do normal cells from outside.
Otto Heinrich Warburg (; 8 October 1883 – 1 August 1970) In 1931 was awarded the Nobel Prize in Physiology for his "discovery of the nature and mode of action of the respiratory enzyme.
WARNBURG EFFECT : cancer cells under aerobic (well-oxygenated) conditions to metabolize glucose to lactate (aerobic glycolysis) is known as the Warburg effect. Warburg made the observation that tumor slices consume glucose and secrete lactate at a higher rate than normal tissues.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Seminar of U.V. Spectroscopy by SAMIR PANDASAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...University of Maribor
Slides from:
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Track: Artificial Intelligence
https://www.etran.rs/2024/en/home-english/
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
A brief information about the SCOP protein database used in bioinformatics.
The Structural Classification of Proteins (SCOP) database is a comprehensive and authoritative resource for the structural and evolutionary relationships of proteins. It provides a detailed and curated classification of protein structures, grouping them into families, superfamilies, and folds based on their structural and sequence similarities.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Multi-source connectivity as the driver of solar wind variability in the heli...
DNATrax (DNA Tagged Reagents for Aerosol eXperiments) by George Farquar, LLNL scientist
1. Powdered sugar, its not just for doughnuts anymore
LLNL-PRES-642415
This work was performed under the auspices of the
U.S. Department of Energy by Lawrence Livermore
National Laboratory under contract DE-AC52-07NA27344.
Lawrence Livermore National Security, LLC
George Farquar, PhD
IMAGE
2. Aerosol: suspension of fine solid particles or liquid droplets in
a gas
Biosecurity
Track airborne contaminants
Environmental effects
Human health effects
Lawrence Livermore National Laboratory LLNL-PRES-642415
3. DNA barcoded particles for aerosol transport studies and source
attribution
The simulant is an inert, non-living, non-viable, non-infectious
material.
It consist of two parts:
1. Non-biological DNA molecules used for identification
2. Sugar (a food-grade carbohydrate
encapsulation material, i.e. Maltodextrin)
100 DNA base pairs allows for 1.6x1060 possible barcodes
(Unlimited)
Lawrence Livermore National Laboratory LLNL-PRES-642415
3
FDA approved food based material, found in
sweeteners and other products
4. “…As a result of the support received from DTRA and LLNL as a part of this testing,
PFPA has been able to make marked performance improvements to the Pentagon’s
biological detection system…”
Jonathan Cofer, Deputy Director of PFPA
Lawrence Livermore National Laboratory LLNL-PRES-642415
5. Testing occurred on November 2012 and February 2013
Primary objective was to determine the suitability of the new simulant as a tool for validation testing of aerosol
systems.
• Four releases occurred. Evaluating initial concept and a simultaneous release.
• PFPA sensors were triggered and all filters collected from DFU’s and swabs were positive for the test material.
• PFPA models were evaluated and compared to experimental data.
Lawrence Livermore National Laboratory LLNL-PRES-642415
5
Data collected with:
Dry Filter Units (DFUs)
Handheld particle counters
(MET one)
Aerodynamic Particle Sizer (APS)
Spectrometer
6. DNATrax
• Safe—made with sugar!
• Multiple releases can be conducted in a short time
period or simultaneously
• Post-testing cleanup is minimal
• Low burden for approval
• Tunable particle size
• Traditional Spores
• Cleanup required
• Difficulty obtaining approval for
releases
• Single release
• Barcoded Spores
• Difficult to receive approval to release
genetically modified organisms
• Tracer chemicals (gases)
• Single releases
• Vastly different transport properties from
1-10 micron particles
Lawrence Livermore National Laboratory LLNL-PRES-642415